- Home
- LGVN vs AAME Comparison
LGVN vs AAME Comparison
Compare LGVN & AAME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGVN
- AAME
- Stock Information
- Founded
- LGVN 2014
- AAME 1968
- Country
- LGVN United States
- AAME United States
- Employees
- LGVN N/A
- AAME N/A
- Industry
- LGVN Medicinal Chemicals and Botanical Products
- AAME Life Insurance
- Sector
- LGVN Health Care
- AAME Finance
- Exchange
- LGVN Nasdaq
- AAME Nasdaq
- Market Cap
- LGVN 23.4M
- AAME 35.1M
- IPO Year
- LGVN 2021
- AAME N/A
- Fundamental
- Price
- LGVN $1.24
- AAME $1.69
- Analyst Decision
- LGVN Strong Buy
- AAME
- Analyst Count
- LGVN 3
- AAME 0
- Target Price
- LGVN $8.67
- AAME N/A
- AVG Volume (30 Days)
- LGVN 123.3K
- AAME 11.0K
- Earning Date
- LGVN 05-08-2025
- AAME 05-13-2025
- Dividend Yield
- LGVN N/A
- AAME 1.18%
- EPS Growth
- LGVN N/A
- AAME N/A
- EPS
- LGVN N/A
- AAME N/A
- Revenue
- LGVN $2,225,000.00
- AAME $191,355,000.00
- Revenue This Year
- LGVN N/A
- AAME N/A
- Revenue Next Year
- LGVN $17.49
- AAME N/A
- P/E Ratio
- LGVN N/A
- AAME N/A
- Revenue Growth
- LGVN 127.50
- AAME 2.04
- 52 Week Low
- LGVN $0.77
- AAME $1.25
- 52 Week High
- LGVN $6.40
- AAME $1.99
- Technical
- Relative Strength Index (RSI)
- LGVN 37.16
- AAME 54.05
- Support Level
- LGVN $1.25
- AAME $1.64
- Resistance Level
- LGVN $1.37
- AAME $1.92
- Average True Range (ATR)
- LGVN 0.09
- AAME 0.08
- MACD
- LGVN -0.01
- AAME -0.01
- Stochastic Oscillator
- LGVN 1.75
- AAME 28.13
About LGVN Longeveron Inc.
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.
About AAME Atlantic American Corporation
Atlantic American Corp operates in specialty markets within the life and health and property and casualty insurance industries. The company has two segments: American Southern, It provides property and casualty insurance including bodily injury and property damage liability coverage, uninsured motorist coverage, and physical damage coverage for commercial accounts, and Bankers Fidelity, the company's life and health operations offer a variety of life and supplemental health products including ordinary and term life insurance, Medicare supplement, and other health insurance.